Article info
PDFPostScript
Letter
Off-label use of paracetamol in managing patent ductus arteriosus across neonatal intensive care units in the UK
- Correspondence to Dr Arindam Mukherjee, St Mary's Hospital, Departmernt of Neonatology, Manchester University NHS Foundation Trust, Manchester M13 9WL, UK; arindam.mukherjee{at}mft.nhs.uk
Citation
Off-label use of paracetamol in managing patent ductus arteriosus across neonatal intensive care units in the UK
Publication history
- Accepted September 20, 2020
- First published October 26, 2020.
Online issue publication
December 11, 2020
Article Versions
- Previous version (26 October 2020).
- Previous version (4 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.